Cargando…
Potential immunotherapy for Alzheimer disease and age-related dementia
Emerging results support the concept that Alzheimer disease (AD) and age-related dementia are affected by the ability of the immune system to contain the brain's pathology. Accordingly, well-controlled boosting, rather than suppression of systemic immunity, has been suggested as a new approach...
Autores principales: | Schwartz, Michal, Arad, Michal, Ben-Yehuda, Hila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780363/ https://www.ncbi.nlm.nih.gov/pubmed/31607777 |
Ejemplares similares
-
Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
por: Ben-Yehuda, Hila, et al.
Publicado: (2021) -
Zinc-mediated Neurotransmission in Alzheimer’s Disease: A Potential Role of the GPR39 in Dementia
por: Rychlik, Michal, et al.
Publicado: (2020) -
Maternal Type-I interferon signaling adversely affects the microglia and the behavior of the offspring accompanied by increased sensitivity to stress
por: Ben-Yehuda, Hila, et al.
Publicado: (2019) -
Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias
por: Turner, R. Scott, et al.
Publicado: (2020) -
Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers
por: Stocker, Hannah, et al.
Publicado: (2023)